~6 spots leftby Aug 2025

PCEA vs IV PCA for Postoperative Pain Management After Liver Surgery

Recruiting in Palo Alto (17 mi)
+3 other locations
VA
Overseen byVittoria Arslan-Carlon, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 3
Waitlist Available
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo Group
Pivotal Trial (Near Approval)
Prior Safety Data

Trial Summary

What is the purpose of this trial?

The purpose of this study is to learn whether patient-controlled epidural analgesia (PCEA) is a better method for managing pain after liver resection compared to patient-controlled analgesia (IV PCA). Currently, the standard pain control method for liver resection patients is IV PCA. There is not enough data on how epidural (PCEA) relieves pain and movement on a day to day basis after liver resection.

Research Team

VA

Vittoria Arslan-Carlon, MD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Eligibility Criteria

Adults over 18 who can consent and are undergoing elective liver resection for liver disease, including additional surgeries, without contraindications to epidural catheter insertion. Excluded are those with allergies to study drugs, pain at rest or movement (NRS >2), opioid agonist/antagonist use, bleeding disorders, neurological issues, extensive spinal history or deformity, certain pre-op coagulopathy levels or infections at the epidural site.

Inclusion Criteria

I am 18 years or older and can give my consent.
I am having liver surgery for a liver condition or liver cancer, and I can safely have an epidural.

Exclusion Criteria

You have a serious problem with memory or thinking, or you have a documented mental health issue.
I am currently taking medication that includes opioids.
You have cirrhosis, which is a liver condition. If it's found during surgery, you can't be in the study, but you'll still be checked for the study's main goals.
See 6 more

Treatment Details

Interventions

  • IV PCA (Procedure)
  • PCEA (Procedure)
Trial OverviewThe trial is testing if patient-controlled epidural analgesia (PCEA) manages post-operative pain better than the standard intravenous patient-controlled analgesia (IV PCA) after liver resection surgery. It aims to compare daily pain relief and mobility between these two methods.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: PCEA during and after surgeryExperimental Treatment1 Intervention
general anesthesia with post-operative thoracic epidural analgesia with a standard demand pump
Group II: IV PCA after surgeryActive Control1 Intervention
general anesthesia with post-operative IV PCA with a standard demand pump

Find a Clinic Near You

Who Is Running the Clinical Trial?

Memorial Sloan Kettering Cancer Center

Lead Sponsor

Trials
1,998
Recruited
602,000+
Lisa M. DeAngelis profile image

Lisa M. DeAngelis

Memorial Sloan Kettering Cancer Center

Chief Medical Officer since 2021

MD from Columbia University

Selwyn M. Vickers profile image

Selwyn M. Vickers

Memorial Sloan Kettering Cancer Center

Chief Executive Officer since 2022

MD from Johns Hopkins University